A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes

Study to Evaluate Safety, Tolerability, Pharmacokinetics & Pharmacodynamics of JTT-662 in Subjects With Type 2 Diabetes

NCT04465877 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Study In Japanese Subjects With Type 2 Diabetes Mellitus As Monotherapy

NCT02292433 ·Status: COMPLETED ·Phase: PHASE1

Study of Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single Oral Doses of JTT-252

NCT02120976 ·Status: TERMINATED ·Phase: PHASE1

Phase II Dose-Finding Study of SK-0403 With Type 2 Diabetes Mellitus

NCT00532506 ·Status: COMPLETED ·Phase: PHASE2

An Exploratory Study of DS-8500a on Beta Cell Function Using Hyperglycemic Clamp

NCT02669732 ·Status: COMPLETED ·Phase: NA

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06882961 in Japanese Adults With Type 2 Diabetes Mellitus

NCT04552470 ·Status: COMPLETED ·Phase: PHASE1

A Study of DS-8500a in Japanese Subjects With Type 2 Diabetes Mellitus Receiving Sitagliptin

NCT02685345 ·Status: COMPLETED ·Phase: PHASE2

A Study of the Safety, Pharmacokinetics, and Pharmacodynamics of CNTO 3649 in Healthy Adults and Patients With Type 2 Diabetes Mellitus

NCT00882726 ·Status: COMPLETED ·Phase: PHASE1

A 6-Week Study Of PF-05175157 In Type 2 Diabetes Mellitus

NCT01792635 ·Status: TERMINATED ·Phase: PHASE2

Pharmacokinetic/Pharmacodynamic Study of MP-513 With Type 2 Diabetes Mellitus

NCT01072331 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Pharmacokinetics and Safety Between Single Oral Administration of BR3006 and Co-administration of BR3006A, BR3006B and BR3006C in Healthy Adult Volunteers Under Fed Conditions

NCT06890299 ·Status: COMPLETED ·Phase: PHASE1

Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Multiple Rising Oral Doses of BI 14332 CL as Tablet in Female and Male Patients With Type 2 Diabetes

NCT02212925 ·Status: TERMINATED ·Phase: PHASE1

Randomized, Placebo-controlled, 2 Period, Single-blind, Sequential, Multiple Ascending Dose Study

NCT01956305 ·Status: COMPLETED ·Phase: PHASE1

A Phase 1 Single/Multiple Dose Study Of PF-06293620 To Assess Safety, Tolerability And Pharmacokinetics In Subjects With Type 2 Diabetes Mellitus

NCT02211261 ·Status: COMPLETED ·Phase: PHASE1

Safety and Pharmacokinetics Study of XOMA 052 in Subjects With Type 2 Diabetes Mellitus

NCT00513214 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

A Study Of BRL49653C For The Treatment Of Type 2 Diabetes (Combination Therapy With Sulfonyl Urea) -With Placebo Study

NCT00432679 ·Status: COMPLETED ·Phase: PHASE3

Multiple Dose Study Of PF-04937319 In Patients With Type 2 Diabetes

NCT01272804 ·Status: COMPLETED ·Phase: PHASE1

Specific Clinical Experience Investigation for Long-term Use of Bydureon.

NCT01940770 ·Status: COMPLETED

Omarigliptin Add-on to Insulin in Japanese Participants With Type 2 Diabetes Mellitus (T2DM, MK-3102-039)

NCT02906709 ·Status: COMPLETED ·Phase: PHASE4

Study to Assess the Safety, Tolerability, PK and PD Response of PE0139 Injection in Adult Subjects With T2DM

NCT02581657 ·Status: COMPLETED ·Phase: PHASE2

Safety, Tolerability, and Pharmacokinetic and Pharmacodynamic Characteristics of JP-2266 in Healthy Subjects

NCT05172622 ·Status: UNKNOWN ·Phase: PHASE1

A Phase II Study to Evaluate the Effects of Oral ONO-5129 in Type 2 Diabetes Mellitus

NCT00212641 ·Status: COMPLETED ·Phase: PHASE2

A Trial To Assess The Safety, Tolerability, Pharmacokinetics, And Pharmacodynamics Of Single Doses Of PF-04937319 In Subjects With Type 2 Diabetes Mellitus

NCT01044537 ·Status: COMPLETED ·Phase: PHASE1

Evaluate Safety as Mono or Combination Therapies With Anti-diabetes Mellitus Drugs in Japanese Subjects With Type 2 Diabetes Mellitus

NCT01294436 ·Status: COMPLETED ·Phase: PHASE3

The Safety and Efficacy of Dapagliflozin Therapy in Combination With Insulin in Japanese Subjects With T1DM

NCT02582814 ·Status: COMPLETED ·Phase: PHASE3